Zacks: Analysts Anticipate Safeguard Scientifics, Inc (NYSE:SFE) to Post $1.53 EPS
Equities analysts forecast that Safeguard Scientifics, Inc (NYSE:SFE) will announce $1.53 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics posted earnings per share of ($1.21) in the same quarter last year, which indicates a positive year-over-year growth rate of 226.4%. The company is expected to announce its next earnings report on Thursday, July 25th.
On average, analysts expect that Safeguard Scientifics will report full year earnings of $1.37 per share for the current year. For the next fiscal year, analysts expect that the firm will report earnings of ($1.70) per share. Zacks’ EPS calculations are a mean average based on a survey of research firms that that provide coverage for Safeguard Scientifics.
Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings data on Thursday, May 2nd. The asset manager reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.25.
Several institutional investors have recently added to or reduced their stakes in SFE. Yakira Capital Management Inc. grew its holdings in shares of Safeguard Scientifics by 2.7% in the first quarter. Yakira Capital Management Inc. now owns 818,289 shares of the asset manager’s stock valued at $8,878,000 after purchasing an additional 21,600 shares in the last quarter. Bank of Montreal Can grew its holdings in shares of Safeguard Scientifics by 1.5% in the first quarter. Bank of Montreal Can now owns 514,945 shares of the asset manager’s stock valued at $5,587,000 after purchasing an additional 7,474 shares in the last quarter. Almitas Capital LLC grew its holdings in shares of Safeguard Scientifics by 63.5% in the first quarter. Almitas Capital LLC now owns 402,998 shares of the asset manager’s stock valued at $4,373,000 after purchasing an additional 156,580 shares in the last quarter. Zeke Capital Advisors LLC purchased a new position in shares of Safeguard Scientifics in the first quarter valued at $2,212,000. Finally, Geode Capital Management LLC grew its holdings in shares of Safeguard Scientifics by 5.1% in the fourth quarter. Geode Capital Management LLC now owns 191,298 shares of the asset manager’s stock valued at $1,648,000 after purchasing an additional 9,318 shares in the last quarter. Hedge funds and other institutional investors own 68.28% of the company’s stock.
Shares of Safeguard Scientifics stock traded down $0.27 on Monday, hitting $11.39. 59,643 shares of the company traded hands, compared to its average volume of 66,400. The firm has a market cap of $239.92 million, a PE ratio of -14.99 and a beta of 0.88. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.03. Safeguard Scientifics has a 52 week low of $7.98 and a 52 week high of $12.91. The company’s 50-day moving average price is $12.11.
About Safeguard Scientifics
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Featured Story: The Structure of a Futures Contract
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.